Clinical Trial Update: A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of dostarlimab for untreated dMMR/MSI-H locally advanced rectal cancer, which is currently active and not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Dostarlimab (dostarlimab)
• JEMPERLI (DOSTARLIMAB)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Rectal | Phase 2 | Status: ACTIVE_NOT_RECRUITING